Valeant Again Boosts Skin Care Biz With $500M PreCision Buy

Law360, New York (February 3, 2014, 1:20 PM EST) -- Valeant Pharmaceutical International Inc., one of the most acquisitive life sciences companies in recent years, said Monday it will pay up to $500 million to fold PreCision Dermatology Inc. into its growing skin care business.

Under the transaction's terms, Quebec-based Valeant will pony up $475 million in cash, plus another $25 million if PreCision hits unspecified sales milestones. The deal adds to a string of pickups aimed at bringing Valeant into the top five drug companies, based on market capitalization, by 2015.

The company has said...
To view the full article, register now.